According to Medifast's latest financial reports the company's current revenue (TTM ) is A$0.94 Billion. a decrease over the revenue in the year 2023 that were of A$1.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | A$0.96 B | -38.45% |
2023 | A$1.57 B | -33.02% |
2022 | A$2.34 B | 11.6% |
2021 | A$2.10 B | 73.14% |
2020 | A$1.21 B | 19.27% |
2019 | A$1.01 B | 43.33% |
2018 | A$0.71 B | 84.11% |
2017 | A$0.38 B | 1.42% |
2016 | A$0.38 B | 1.72% |
2015 | A$0.37 B | 14.83% |
2014 | A$0.32 B | -18.5% |
2013 | A$0.40 B | 16.56% |
2012 | A$0.34 B | 18.03% |
2011 | A$0.29 B | 14.7% |
2010 | A$0.25 B | 35.07% |
2009 | A$0.18 B | 25.6% |
2008 | A$0.14 B | 55.97% |
2007 | A$95.82 M | 1.96% |
2006 | A$93.98 M | 71.36% |
2005 | A$54.84 M | 55.24% |
2004 | A$35.32 M | 3.47% |
2003 | A$34.14 M | 55.82% |
2002 | A$21.91 M | 122.67% |
2001 | A$9.84 M | 41.15% |
2000 | A$6.97 M |